Limit NSAIDs in Patients With Cardiovascular Disease
You'll see even stronger CV warnings for Rx and OTC NSAIDs.
For example, labels will clarify that NSAIDs slightly increase CV risk in patients with OR without CV disease. They'll also say risk goes up within DAYS of use...and with higher NSAID doses and longer durations.
A big study will shed light on NSAID risks...but not until 2016.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote